FDA Inspection 821892 — Roswell Park Cancer Institute Corporation. Div. Of Pathology
The FDA completed an inspection of Roswell Park Cancer Institute Corporation. Div. Of Pathology on Mar 1, 2013 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Buffalo, NY (United States)